Skip to main content

Advertisement

SpringerLink
Log in

Psychosocial Mediators of Change and Patient Selection Factors in Oral Immunotherapy Trials

  • Published:
Clinical Reviews in Allergy & Immunology Aims and scope Submit manuscript

Abstract

Health-related quality of life (HRQL) is influenced by physiological, psychological, and environmental variables and can be best understood by considering the interactions of factors that cut across multiple levels. One of the most important issues relating to treatment in food allergy is to identify, describe, and define predictors that may contribute to modify HRQL outcomes. The research presented demonstrates that measures of HRQL are able to distinguish key features of known groups (e.g. relating to reaction severity, treatment, allergen type/number, expectation of outcome) and delineate impact on hitherto unknown groups (e.g. relating to personality types and coping styles). This heterogeneity may explain why HRQL or other patient-related outcomes may differ in individuals during, or following any treatment or intervention. Patient-reported outcomes are relatively poorly defined to date. Since HRQL has only been studied in relatively few oral immunotherapy trials to date, primarily looking at caregiver HRQL, it is unclear which factors, measures, or subscales are most predictive of short- and/or long-term treatment outcomes for which type of patient, and which time points for measurement are most informative. A standardised protocol that incorporates HRQL and other relevant patient-related outcome measures and agreed definitions of outcomes would allow for the comparison of efficacy of food allergy treatments between centres, trials, or countries. Further evidence-based research aimed at exploring the effects of interventions on outcomes in food allergy is needed, including the influence of patient and parent factors on protocol design. To this end, it is vital that patient-related outcomes such as improved HRQL are seen as a primary outcome and are measured at multiple intervals during the trial duration and beyond. The creative use of methods and designs (both qualitative and quantitative) to better understand the role of HRQL in immunotherapy treatment trials will enable improved modelling of the costs, risks, and benefits of any treatment. Systematic analysis and modelling of antecedent factors, mediators, and outcomes will be important to boost intervention effects and to maximise the overall benefits of treatment.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6
Fig. 7
Fig. 8

Similar content being viewed by others

References

  1. Prescott S, Allen KJ (2011) Food allergy: riding the second wave of the allergy epidemic. Pediatr Allergy Immunol 22:155–160

    Article  Google Scholar 

  2. Burks AW, Tang M, Sicherer S, Muraro A, Eigenmann PA, Ebisawa M, Fiocchi A, Chiang W, Beyer K, Wood R, Hourihane J, Jones SM, Lack G, Sampson HA (2012) ICON: food allergy. J Allergy Clin Immunol 129:906–920

    Article  Google Scholar 

  3. Gupta RS, Springston EE, Warrier MR, Smith B, Kumar R, Pongracic J, Holl JL (2011) The prevalence, severity, and distribution of childhood food allergy in the United States. Pediatrics 128:e9–e17

    Article  Google Scholar 

  4. Liew WK, Williamson E, Tang ML (2009) Anaphylaxis fatalities and admissions in Australia. J Allergy Clin Immunol 123:434–442

    Article  Google Scholar 

  5. Mullins RJ, Dear KB, Tang ML (2015) Time trends in Australian hospital anaphylaxis admissions in 1998-1999 to 2011-2012. J Allergy Clin Immunol 136:367–375

    Article  Google Scholar 

  6. Turner PJ, Gowland MH, Sharma V, Ierodiakonou D, Harper N, Garcez T, Pumphrey R, Boyle RJ (2015) Increase in anaphylaxis-related hospitalizations but no increase in fatalities: an analysis of United Kingdom national anaphylaxis data, 1992-2012. J Allergy Clin Immunol 135(4):956–963

    Article  PubMed Central  Google Scholar 

  7. Branum AM, Lukacs SL (2009) Food allergy among children in the United States. Pediatrics 124:1549–1555

    Article  Google Scholar 

  8. Sicherer SH, Forman JA, Noone SA (2000) Use assessment of self-administered epinephrine among food-allergic children and pediatricians. Pediatrics 105:359–362

    Article  CAS  Google Scholar 

  9. de Silva IL, Mehr SS, Tey D, Tang ML (2008) Paediatric anaphylaxis: a 5 year retrospective review. Allergy 63:1071–1076

    Article  Google Scholar 

  10. Umasunthar T, Leonardi-Bee J, Hodes M, Turner PJ, Gore C, Habibi P, Warner JO, Boyle RJ (2013) Incidence of fatal food anaphylaxis in people with food allergy: a systematic review and meta-analysis. Clin Exp Allergy 43:1333–1341

    Article  CAS  PubMed Central  Google Scholar 

  11. Wassenberg J, Cochard MM, Dunngalvin A, Ballabeni P, Flokstra-de Blok BM, Newman CJ et al (2012) Parent perceived quality of life is age-dependent in children with food allergy. Pediatr Allergy Immunol 23:412–419

    Article  Google Scholar 

  12. Grabenhenrich L, Hompes S, Gough H, Ruëff F, Scherer K, Pföhler C, Treudler R, Mahler V, Hawranek T, Nemat K, Koehli A, Keil T, Worm M (2012) Implementation of anaphylaxis management guidelines: a register-based study. PLoS One 7:e35778

    Article  CAS  PubMed Central  Google Scholar 

  13. Dunn Galvin A, Hourihane JOB (2016) Health-related quality of life in food allergy: Impact, correlates, and predictors. Bundesgesundheitsbl © Springer-Verlag, Berlin Heidelberg

    Google Scholar 

  14. Varni J, Burwinkle T, Lane M (2005) Health-related quality of life measurement in pediatric clinical practice: an appraisal and precept for future research and application. Health Qual Life Outcomes 3:34

    Article  PubMed Central  Google Scholar 

  15. Cummings AJ, Knibb RC, King RM, Lucas JS (2010) The psychosocial impact of food allergy and food hypersensitivity in children, adolescents and their families: a review. Allergy 65(8):933–945

    Article  CAS  Google Scholar 

  16. King RM, Knibb RC, Hourihane JO (2009) Impact of peanut allergy on quality of life, stress and anxiety in the family. Allergy 64:461–468

    Article  CAS  Google Scholar 

  17. Lyons AC, Forde EM (2004) Food allergy in young adults: perceptions and psychological effects. J Health Psychol 9:497–504

    Article  Google Scholar 

  18. Sicherer SH, Noone SA, Munoz-Furlong A (2001) The impact of childhood food allergy on quality of life. Ann Allergy Asthma Immunol 87:461–464

    Article  CAS  Google Scholar 

  19. Acquadro C, Berzon R, Dubois D, Leidy NK, Marquis P, Revicki D, Rothman M, PRO Harmonization Group (2003) Incorporating the patient’s perspective into drug development and communication: an ad hoc task force report on the patient-reported outcomes (PRO) harmonization group meeting at the Food and Drug Administration, February 16, 2001. Value Health 5:522–531

    Article  Google Scholar 

  20. Burke LB, Kennedy DL, Miskala PH, Papadopoulos EJ, Trentacosti AM (2008) The use of patient-reported outcome measures in the evaluation of medical products for regulatory approval. Clin Pharmacol Ther 84:281–283. https://doi.org/10.1038/clpt.2008.128

    Article  CAS  PubMed  Google Scholar 

  21. The Six Domains of Health Care Quality. Content last reviewed. October 2017. Agency for Healthcare Research and Quality, Rockville, MD. http://www.ahrq.gov/professionals/quality-patient safety/talkingquality/create/sixdomains.html

  22. Patrick DL, Burke LB, Powers JH, Scott JA, Rock EP, Dawisha S, O’Neill R, Kennedy DL (2007) Patient-reported outcomes to support medical product labeling claims: FDA perspective. Value Health 10(Suppl 2):S125–S137

    Article  Google Scholar 

  23. US Department of Health and Human Services, US Food and Drug Administration (2009) Guidance for industry: patient-reported outcome measures. use in medical product development to support labeling claims. US Food and Drug Administration, Washington, DC

  24. European Medicines Agency, Committee for Medicinal Products for Human Use (CMHP) (2005) Reflection paper on the regulatory guidance for the use of Health-Related Quality of Life (HRQL) measures in the evaluation of medicinal products. European Medicines Agency, London

  25. Flokstra-de Blok BMJ, Dubois AEJ, Vlieg-Boerstra BJ, Oude Elberink JNG, Raat H, DunnGalvin A, Hourihane JOB, Duiverman EJ (2010) Health-related quality of life of food allergic patients: comparison with the general population and other diseases. Allergy 65:238–244

    Article  CAS  Google Scholar 

  26. Goossens NJ, Flokstra-de Blok BM, van der Meulen GN, Arnlind MH, Asero R, Barreales L et al (2014) Health-related quality of life in food-allergic adults from eight European countries. Ann Allergy Asthma Immunol 113(63–8):e1

    Google Scholar 

  27. Dunn Galvin A et al (2016) An examination of the Food Allergy Quality of Life Questionnaire performance in a countrywide American sample of children: cross-cultural differences in age and impact in the United States and Europe. J Allergy Clin Immunol Pract 5(2):363–368.e2

    Article  Google Scholar 

  28. Flokstra-de Blok BM, Dubois AE (2012) Quality of life measures for food allergy. Clin Exp Allergy 42:1014–1020

    Article  CAS  Google Scholar 

  29. Flokstra-de Blok BM, Dubois AE (2009) Quality of life in food allergy: valid scales for children and adults. Curr Opin Allergy Clin Immunol 9:214–221

    Article  Google Scholar 

  30. Flokstra-de Blok BM, Dunn Galvin A, Vlieg-Boerstra BJ, Oude Elberink JN, Duiverman EJ, Hourihane JO et al (2009) Development and validation of a self-administered Food Allergy Quality of Life Questionnaire for children. Clin Exp Allergy 39:127–137

    Article  CAS  Google Scholar 

  31. Flokstra-de Blok BM, Dunn Galvin A, Vlieg-Boerstra BJ, Oude Elberink JN, Duiverman EJ, Hourihane JO et al (2008) Development and validation of the self-administered Food Allergy Quality of Life Questionnaire for adolescents. J Allergy Clin Immunol 122:139–144

    Article  Google Scholar 

  32. Flokstra-de Blok BM, van der Meulen GN, Dunn Galvin A, Vlieg-Boerstra BJ, Oude Elberink JN, Duiverman EJ et al (2009) Development and validation of the Food Allergy Quality of Life Questionnaire - adult form. Allergy 64:1209–1217

    Article  CAS  Google Scholar 

  33. Dunn Galvin A, Flokstra de Blok BM, Burks AW, Dubois AE, Hourihane JO (2008) Food allergy QoL questionnaire for children aged 0-12 years: content, construct, and cross-cultural validity. Clin Exp Allergy 38:977–986

    Article  CAS  Google Scholar 

  34. Dunn Galvin A, Cullinane C, Daly D, Flokstra-de Blok B, Dubois A, Hourihane J (2010) Longitudinal validity and responsiveness of the Food Allergy Quality of Life Questionnaire–Parent Form in children 0–12 years following positive and negative food challenges. Clin Exp Allergy 40:476–485

    Article  CAS  Google Scholar 

  35. van der Velde JL, Flokstra-de Blok BM, Vlieg-Boerstra BJ, Oude Elberink JN, Schouten JP, Dunngalvin A et al (2009) Testretest reliability of the Food Allergy Quality of Life Questionnaires (FAQLQ) for children, adolescents and adults. Qual Life Res 18:245–251

    Article  Google Scholar 

  36. Ferrans CA, Zerwic JJ, Wilbur JE, Larson JL (2005) Conceptual model of health-related quality of life. J Nurs Scholarsh 37:336–342

    Article  Google Scholar 

  37. Flokstra-de Blok BMJ (2014) Food Allergy Quality of Life Questionnaires (FAQLQ) Encyclopedia of quality of life and well-being research. Springer, p 2319–322

  38. Buchanan AD, Green TD, Jones SM, Scurlock AM, Christie L, Althage KA et al (2007) Egg oral immunotherapy in nonanaphylactic children with egg allergy. J Allergy Clin Immunol 119:199–205

    Article  CAS  Google Scholar 

  39. Kim EH, Bird JA, Kulis M, Laubach S, Pons L, Shreffler W et al (2011) Sublingual immunotherapy for peanut allergy: clinical and immunologic evidence of desensitization. J Allergy Clin Immunol 127:640–646

    Article  CAS  PubMed Central  Google Scholar 

  40. Keet CA, Frischmeyer-Guerrerio PA, Thyagarajan A, Schroeder JT, Hamilton RG, Boden S, Steele P, Driggers S, Burks AW, Wood RA (2012) The safety and efficacy of sublingual and oral immunotherapy for milk allergy. J Allergy Clin Immunol 129:448–455

    Article  CAS  Google Scholar 

  41. Anagnostou K, Islam S, King Y, Foley L, Pasea L, Bond S, Palmer C, Deighton J, Ewan P, Clark A (2014) Assessing the efficacy of oral immunotherapy for the desensitisation of peanut allergy in children (STOP II): a phase 2 randomised controlled trial. Lancet 383:1297–1304

    Article  CAS  PubMed Central  Google Scholar 

  42. Anagnostou K, Clark A (2014) Peanut immunotherapy. Clin Transl Allergy 4:30

    Article  PubMed Central  Google Scholar 

  43. Dupont C, Kalach N, Soulaines P, Legoue-Morillon S, Piloquet H, Benhamou PH (2010) Cow’s milk epicutaneous immunotherapy in children: a pilot trial of safety, acceptability, and impact on allergic reactivity. J Allergy Clin Immunol 125:1165–1167

    Article  CAS  Google Scholar 

  44. Nadeau KC, Schneider LC, Hoyte L, Borras I, Umetsu DT (2011) Rapid oral desensitization in combination with omalizumab therapy in patients with cow’s milk allergy. J Allergy Clin Immunol 127:1622–1624

    Article  PubMed Central  Google Scholar 

  45. Nurmatov U, Dhami S, Arasi S, Pajno GB, Fernandez-Rivas M, Muraro A, Roberts G, Akdis C, Alvaro-Lozano M, Beyer K, Bindslev-Jensen C, Burks W, du Toit G, Ebisawa M, Eigenmann P, Knol E, Makela M, Nadeau KC, O’Mahony L, Papadopoulos N, Poulsen LK, Sackesen C, Sampson H, Santos AF, van Ree R, Timmermans F, Sheikh A (2017) Allergen immunotherapy for IgE-mediated food allergy: a systematic review and meta-analysis. Allergy 72:1133–1147

    Article  CAS  Google Scholar 

  46. Chin SJ, Vickery BP, Kulis MD, Kim EH, Varshney P, Steele P, Kamilaris J, Hiegel AM, Carlisle SK, Smith PB, Scurlock AM, Jones SM, Burks AW (2013) Sublingual versus oral immunotherapy for peanut-allergic children: a retrospective comparison. J Allergy Clin Immunol 132:476–478

    Article  CAS  PubMed Central  Google Scholar 

  47. Agbotounoi W, Martin L, Dupont D, Pascal I, Vauleon C, Benhamou PH (2012) Epicutaneous immunotherapy (EPIT) is safe for the treatment of peanut allergy in allergic patients [abstract]. J Allergy Clin Immunol 131(2 Suppl):AB91

    Google Scholar 

  48. Hofmann AM, Scurlock AM, Jones SM, Palmer KP, Lokhnygina Y, Steele PH, Kamilaris J, Burks AW (2009) Safety of a peanut oral immunotherapy protocol in children with peanut allergy. J Allergy Clin Immunol 124:286–291

    Article  CAS  PubMed Central  Google Scholar 

  49. Muraro A, Dubois AE, Dunn Galvin A et al (2014) EAACI Food Allergy and Anaphylaxis Guidelines. Food allergy health-related quality of life measures. Allergy 69:845–853

    Article  CAS  Google Scholar 

  50. Avery NJ, King RM, Knight S, Hourihane JO (2003) Assessment of quality of life in children with peanut allergy. Pediatr Allergy Immunol 14:378–382

    Article  Google Scholar 

  51. Polloni L, Baldi I, Lazzarotto F, Bonaguro R, Toniolo A, Gregori D, Muraro A (2015) Multidimensional analysis of food-allergic children and adolescents’ self-concept: a comparison with a healthy matched sample. J Health Psychol 20(6):850–857

    Article  Google Scholar 

  52. Dunn Galvin A, Gaffney A, Hourihane JO’B (2009) Developmental pathways in food allergy: a new theoretical model. Allergy 64:560–568

    Article  CAS  Google Scholar 

  53. Dunn Galvin A, Polloni L, Le Bovidge J, Muraro A, Greenhawt M, Taylor S, Burks W, Allen K, Sheikh A, Hourihane J, Tang M Development of the Food Allergy Coping and Experience Model (FACE): secondary analysis of data on IgE-mediated food allergy in children, young people and their parents from five countries. (JACI-P, accepted)

  54. DunnGalvin et al (2009) Profiling families enrolled in immunotherapy studies. Pediatrics 142(3):e503–e509

    Article  Google Scholar 

  55. Wang J, Liu AH (2011) Food allergies and asthma. Curr Opin Allergy Clin Immunol 11(3):249–254

    Article  CAS  PubMed Central  Google Scholar 

  56. Klinnert MD, Silveira L, Harris R, Moore W, Atkins D, Fleischer DM, Menard-Katcher C, Aceves S, Spergel JM, Franciosi JP, Furuta GT (2014) Health related quality of life over time in children with eosinophilic esophagitis (EoE) and their families. J Pediatr Gastroenterol Nutr 59(3):308–316

    Article  PubMed Central  Google Scholar 

  57. Cortina S, McGraw K, de Alarcon A et al (2010) Psychological functioning of children and adolescents with eosinophil-associated gastrointestinal disorders. Child Health Care 39:266–278

    Article  PubMed Central  Google Scholar 

  58. Klinnert MD, Moore W, Miller J et al (2011) Impact of eosinophilic esophagitis on quality of life for youth and their families. J Allergy Clin Immunol 127(S):AB110

    Google Scholar 

  59. Mukkada V, Haas A, Creskoff Maune N et al (2010) Feeding dysfunction in children with eosinophilic gastrointestinal diseases. Pediatrics 126:e1–e7

    Article  Google Scholar 

  60. Ingerski L, Modi A, Hood K et al (2010) Health-related quality of life across pediatric chronic conditions. J Pediatr 156:639–644

    Article  PubMed Central  Google Scholar 

  61. Harris RF, Menard-Katcher C, Atkins D, Furuta GT, Klinnert MD (2013) Psychosocial dysfunction in children and adolescents with eosinophilic esophagitis. J Pediatr Gastroenterol Nutr 57:500–505

    Article  Google Scholar 

  62. Dunn Galvin A, Barnett J, Begen FM, Ryan K, Lucas JS (2017) Development and preliminary validation of the Food Intolerance Quality of Life Questionnaire (FIQLQ): adult form. Qual Life Res 27(4):1109–1116. https://doi.org/10.1007/s11136-017-1732-0

    Article  Google Scholar 

  63. Dunn Galvin A PAAM 2017 Symposium. Maternal Anxiety & Food avoidance

  64. DunnGalvin et al (2016) An examination of the Food Allergy Quality of Life Questionnaire performance in a countrywide American sample of children: cross-cultural differences in age and impact in the United States and Europe. J Allergy Clin Immunol Pract 5(2):363–368. https://doi.org/10.1016/j.jaip.2016.09.049

    PubMed  Google Scholar 

  65. McHenry, Watson (2014) Impact of primary food allergies on the introduction of other foods amongst Canadian children and their siblings. Allergy, Asthma Clin Immunol 10(1):26

    Article  Google Scholar 

  66. Barnett J, Muncer K, Leftwich J, Shepherd R, Raats MM, Gowland MH, Grimshaw K, Lucas JS (2011) Using ‘may contain’ labelling to inform food choice: a qualitative study of nut allergic consumers. BMC Public Health 11:734

    Article  PubMed Central  Google Scholar 

  67. Beyer K, Eckermann O, Hompes S, Grabenhenrich L, Worm M (2012) Anaphylaxis in an emergency setting - elicitors, therapy and incidence of severe allergic reactions. Allergy 67:1451–1456

    Article  CAS  Google Scholar 

  68. Kelleher MM, Hourihane JO’B, Dunngalvin A, Cullinane C, Fitzsimons J, Sheikh A (2012) A 24-h helpline for access to expert management advice for food allergy-related anaphylaxis in children: protocol for a pragmatic randomised controlled trial. BMJ 131(2 Suppl):AB219

  69. Calsbeek H, Rijken M, Dekker J, van Berge Henegouwen GP (2006) Disease characteristics as determinants of the labour market position of adolescents and young adults with chronic digestive disorders. Eur J Gastroenterol Hepatol 18:203–209

    Article  Google Scholar 

  70. Shemesh E, Annunziato RA, Ambrose MA, Ravid NL, Mullarkey C, Rubes M, Chuang K, Sicherer M, Sicherer SH (2013) Child and parental reports of bullying in a consecutive sample of children with food allergy. Pediatrics 131:e10–e17. https://doi.org/10.1542/peds.2012-1180

    Article  PubMed  PubMed Central  Google Scholar 

  71. Dunn Galvin A (2017) The experience of eating out on the Island of Ireland in 2013 prior to and following introduction of the ‘Food Information for Consumers Regulation’. Safe Food Report

  72. Dunn Galvin A, Roberts G et al Understanding how consumers with allergies make decisions based on precautionary labelling. Submitted

  73. Compas BE, Jaser SS, Dunn MJ, Rodriguez EM (2012) Coping with chronic illness in childhood and adolescence. Annu Rev Clin Psychol 8:455–480

    Article  Google Scholar 

  74. Greenhawt M, Dunn Galvin A Preliminary psychometric analyses and clinical performance of a caregiver self-efficacy scale for food allergy self-management. Ann Allergy Asthma Immunol (in press)

  75. Baxter P, Jack S (2008) Qualitative case study methodology: study design and implementation for novice researchers. Qual Rep 13(4):544–559

    Google Scholar 

  76. DunnGalvin et al Preliminary Development of the Food Allergy Coping and Emotions (FACE) questionnaires for children, adolescents and young people: qualitative analysis of data on IgE-mediated food allergy from five countries. (JAIP, accepted)

  77. World Health Organisation. Innovative Care for Chronic Conditions: Building Blocks for Action http://www.who.int/chp/knowledge/publications/icccreport/en/ Accessed. October 2017

  78. Bandura A (1977) Self-efficacy: toward a unifying theory of behavioral change. Psychol Rev 84:191–215

    Article  CAS  Google Scholar 

  79. Tamagawa R, Garland S, Vaska M, Carlson LE (2012) Who benefits from psychosocial interventions in oncology? A systematic review of psychological moderators of treatment outcome. J Behav Med 35(6):658–673

    Article  Google Scholar 

  80. Ferro MA, Van Lieshout RJ, Ohayon J, Scott JG (2015) Emotional and behavioral problems in adolescents and young adults with food allergy. Allergy 71(4):532–540. https://doi.org/10.1111/all.12829

    Article  CAS  Google Scholar 

  81. Sifneos PE (1973) The prevalence of “alexithymic” characteristics in psychosomatic patients. Psychother Psychosom 22:255–262

    Article  CAS  Google Scholar 

  82. Baiardini I, Abbà S, Ballauri M, Vuillermoz G, Braido F (2011) Alexithymia and chronic diseases: the state of the art. G Ital Med Lav Ergon 33(1 Suppl A):A47–A52

    PubMed  Google Scholar 

  83. Polloni L, Ferruzza E, Ronconi L, Lazzarotto F, Bonaguro R, Toniolo A, Celegato N, Muraro A (2015) Mental health and behavior of food-allergic adolescents compared to a healthy matched sample. Ann Allergy Asthma Immunol 115(2):158–160

    Article  Google Scholar 

  84. Lumley MA, Stettner L, Wehmer F (1996) How are alexithymia and physical illness linked? A review and critique of pathways. J Psychosom Res 41:505–518

    Article  CAS  Google Scholar 

  85. Kano M, Fukudo S (2013) The alexithymic brain: the neural pathways linking alexithymia to physical disorders. Biopsychosoc Med 7:1

    Article  PubMed Central  Google Scholar 

  86. Bruni R, Serino FM, Galluzzo S, Coppolino G, Cacciapaglia F, Vadacca M et al (2006) Alexithymia and neuroendocrine-immune response in patients with autoimmune diseases: preliminary results on relationship between alexithymic construct and TNF-α levels. Ann N Y Acad Sci 1069:208–211

    Article  CAS  Google Scholar 

  87. Guilbaud O, Curt F, Perrin C, Chaouat G, Berthoz S, Dugré-Le Bigre C et al (2009) Decreased immune response in alexithymic women: a cross-sectional study. Biomed Pharmacother 63:297–304

    Article  CAS  Google Scholar 

  88. Guilbaud O, Corcos M, Hjalmarsson L, Loas G, Jeammet P (2003) Is there a psychoneuroimmunological pathway between alexithymia and immunity? Immune and physiological correlates of alexithymia. Biomed Pharmacother 57:292–295

    Article  Google Scholar 

  89. Knibb RC, Horton SL (2008) Can illness perceptions and coping predict psychological distress amongst allergy sufferers? Br J Health Psychol 13(Pt 1):103–119

    Article  CAS  Google Scholar 

  90. Polloni L, Dunn Galvin A, Ferruzza E, Bonaguro R, Lazzarotto F, Toniolo A, Celegato N, Muraro A (2017) Coping strategies, alexithymia and anxiety in young patients with food allergy. Allergy 72:1054–1060

    Article  CAS  Google Scholar 

  91. Wasserman RL, Sugerman R, Mireku-Akomeah L, Gallucci AR, Pence DM, Long NA (2011) Peanut oral immunotherapy (OIT) of food allergy (FA) carries a significant risk of eosinophilic esophagitis (EoE). JACI 127(Issue 2, Supplement):AB28

    Google Scholar 

  92. Greenhawt M Personal communication. (I have emailed for permission)

  93. Otani M, Bégin P, Kearney C, Dominguez T, Mehrotra A, Bacal LR, Wilson SK (2013) Multi-allergen oral immunotherapy improves quality of life in subjects with food allergies. JACI 131(Issue 2, Supplement):AB58

    Google Scholar 

  94. Otani M, Bégin P, Kearney C, Dominguez T, Mehrotra A, Bacal LR, Wilson SK (2014) Multiple-allergen oral immunotherapy improves quality of life in caregivers of food- allergic pediatric subjects. JACI 10:25

    Google Scholar 

  95. Factor JM, Mendelson L, Lee J, Nouman G, Lester MR (2012) Effect of oral immunotherapy to peanut on food-specific quality of life. Ann Allergy Asthma Immunol 109(5):348–352.e2 08.015

    Article  CAS  Google Scholar 

  96. Tang MLK, Hsiao KC (2016) An update on oral immunotherapy for the treatment of food allergy. Paediatr Child Health 26:304–309

    Article  Google Scholar 

  97. Kuang-Chih H, Ponsonby AL, Axelrad C, Tang M (2017) Long term effects of a probiotic and peanut oral immunotherapy (PPOIT) treatment on peanut allergic children. J Allergy Clin Immunol 139(2 Suppl):AB136

  98. Dunn Galvin A, McMahon, Ponsonby AL, Hsiao KC, Tang MLK (2017) The longitudinal impact of probiotic and peanut oral immunotherapy on health-related quality of life. Allergy 73(3):560–568. https://doi.org/10.1111/all.13330

    Article  Google Scholar 

  99. Gupta RS, Springston EE, Kim JS, Smith B, Pongracic JA, Wang X, Holl J (2010) Food allergy knowledge, attitudes, and beliefs of primary care physicians. Pediatrics 125:126–132

    Article  Google Scholar 

  100. Rabin R, de Charro F (2001) EQ-5D: a measure of health status from the EuroQol Group. Ann Med 33:337–343

    Article  CAS  Google Scholar 

  101. Macran S, Weatherly H, Kind P (2003) Measuring population health: a comparison of three generic health status measures. Med Care 41:218–231.11

    PubMed  Google Scholar 

  102. Martin LR, Williams SL, Haskard KB, DiMatteo MR (2005) The challenge of patient adherence. Ther Clin Risk Manag 1(3):189–199

    PubMed  PubMed Central  Google Scholar 

  103. McKenna SP, Ratcliffe J, Meads DM, Brazier JE (2008) Development and validation of a preference based measure derived from the Cambridge Pulmonary Hypertension Outcome Review (CAMPHOR) for use in cost utility analyses. Health Qual Life Outcomes 6:65

    Article  PubMed Central  Google Scholar 

  104. Doward LC, McKenna SP, Meads DM, Ratcliffe J, Whalley D, Langley PC (2002) Investigation into the feasibility of deriving relative and absolute utility from the Recurrent Genital Herpes Quality of Life Questionnaire (RGHQoL). Value Health 5:573–574

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. School of Applied Psychology, University College Cork, College Road, Cork City, Ireland

    Audrey Dunn Galvin

  2. Department of Paediatrics & Child Health, University College Cork, Cork, Ireland

    Audrey Dunn Galvin & J.O’B. Hourihane

Authors
  1. Audrey Dunn Galvin
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. J.O’B. Hourihane
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Audrey Dunn Galvin.

Ethics declarations

Conflicts of Interest

I am an advisory consultant for Aimmune Therapeutics Biotechnology Company

aimmune.com

Headquarters: Brisbane, CA, USA

Ethical Approval and Informed Consent

All studies cited have obtained ethical approval and participants provided informed consent. The names of any participants and/or identifying information are not included in the manuscript.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Dunn Galvin, A., Hourihane, J. Psychosocial Mediators of Change and Patient Selection Factors in Oral Immunotherapy Trials. Clinic Rev Allerg Immunol 55, 217–236 (2018). https://doi.org/10.1007/s12016-018-8700-5

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12016-018-8700-5

Keywords

Search

Navigation